Royal DSM, a global science-based company, is set to acquire Adare Biome, a company that specializes in postbiotic products. Postbiotics are components of inanimate microorganisms that can confer health benefits. The acquisition is aimed at expanding DSM’s business-to-business (B2B) ingredient offerings for medical nutrition, early life nutrition, dietary supplements, and nutritional improvements for malnourishment. This move is part of DSM’s broader strategy to promote health from the gut and expand its capabilities in the growing pet and animal nutrition market for microbiome management.
According to DSM, the acquisition of Adare Biome will help the company establish itself as a leading player in the postbiotic space. By combining Adare Biome’s expertise with DSM’s global reach and scientific capabilities, the company hopes to develop innovative solutions that promote health and well-being. DSM also sees significant potential for growth in the pet and animal nutrition market, where postbiotic products are becoming increasingly popular for promoting digestive health and immunity.
The acquisition of Adare Biome represents a major step forward in DSM’s strategy to promote health from the gut. By expanding its capabilities in postbiotics, DSM aims to provide customers with a broader range of innovative and effective solutions for addressing a range of health challenges. With the acquisition of Adare Biome, DSM is well-positioned to meet the growing demand for postbiotic products and to play a leading role in shaping the future of health and nutrition.
